Pharma Marketing Network

As I reported back in February this year, Public Citizen urged the FDA to immediately add a black box warning about the increased risks...

Mission T1D - Sanofi Diabetes is on a Mission to Support Children with Type 1 Diabetes through Gaming

Craig DeLarge, until yesterday, Global Leader, Multichannel Marketing Strategy & Innovation at Merck, announced his departure from the pharmaceutical industry on his Facebook timeline. "Yesterday,"...

Bayer’s Grants4Apps: An accelerator run by a pharma company | mobihealthnews

This weekend, Thibaud Guymard (@thibaudguymard), Digital Marketing Manager at MSD France, nominated me (and a few others) to take the ALS "Ice Bucket Challenge."...

This article summarizes some of the main points made by PhRMA, Washington Legal Foundation (WLF), BIO, Medical Information Working Group (MIWG), Patient, Consumer, and Public Health Coalition, and several pharmaceutical companies, regarding FDA's Draft Guidance on using Internet and social media platforms with character space limitations.

This reviews FDA's recommendations for distributing reprints that convey 'new risk information' for approved drugs.

This article asks the question: Can anecdotal 'evidence'/experiences mentioned in patient videos -- even unbranded videos -- cause unnecessary visits to the doctor's office and over prescribing of drugs with serious side effects?

Welcome to Volume 13, Issue #8 (SEPTEMBER 2014) of Pharma Marketing News.

According to the 2014 U.S. Mobile App Report by Comscore, U.S. digital consumers now spend more time using mobile apps than they do  on...